Unknown

Dataset Information

0

Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis.


ABSTRACT: AIMS: Coxsackievirus B3 (CVB3)-induced myocarditis, initially considered a sole immune-mediated disease, also results from a direct CVB3-mediated injury of the cardiomyocytes. Mesenchymal stem cells (MSCs) have, besides immunomodulatory, also anti-apoptotic features. In view of clinical translation, we first analysed whether MSCs can be infected by CVB3. Next, we explored whether and how MSCs could reduce the direct CVB3-mediated cardiomyocyte injury and viral progeny release, in vitro, in the absence of immune cells. Finally, we investigated whether MSC application could improve murine acute CVB3-induced myocarditis. METHODS AND RESULTS: Phase contrast pictures and MTS viability assay demonstrated that MSCs did not suffer from CVB3 infection 4-12-24-48 h after CVB3 infection. Coxsackievirus B3 RNA copy number decreased in this time frame, suggesting that no CVB3 replication took place. Co-culture of MSCs with CVB3-infected HL-1 cardiomyocytes resulted in a reduction of CVB3-induced HL-1 apoptosis, oxidative stress, intracellular viral particle production, and viral progeny release in a nitric oxide (NO)-dependent manner. Moreover, MSCs required priming via interferon-? (IFN-?) to exert their protective effects. In vivo, MSC application improved the contractility and relaxation parameters in CVB3-induced myocarditis, which was paralleled with a reduction in cardiac apoptosis, cardiomyocyte damage, left ventricular tumour necrosis factor-? mRNA expression, and cardiac mononuclear cell activation. Mesenchymal stem cells reduced the CVB3-induced CD4- and CD8- T cell activation in an NO-dependent way and required IFN-? priming. CONCLUSION: We conclude that MSCs improve murine acute CVB3-induced myocarditis via their anti-apoptotic and immunomodulatory properties, which occur in an NO-dependent manner and require priming via IFN-?.

SUBMITTER: Van Linthout S 

PROVIDER: S-EPMC3164101 | biostudies-literature | 2011 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis.

Van Linthout S S   Savvatis K K   Miteva K K   Peng J J   Ringe J J   Warstat K K   Schmidt-Lucke C C   Sittinger M M   Schultheiss H-P HP   Tschöpe C C  

European heart journal 20101222 17


<h4>Aims</h4>Coxsackievirus B3 (CVB3)-induced myocarditis, initially considered a sole immune-mediated disease, also results from a direct CVB3-mediated injury of the cardiomyocytes. Mesenchymal stem cells (MSCs) have, besides immunomodulatory, also anti-apoptotic features. In view of clinical translation, we first analysed whether MSCs can be infected by CVB3. Next, we explored whether and how MSCs could reduce the direct CVB3-mediated cardiomyocyte injury and viral progeny release, in vitro, i  ...[more]

Similar Datasets

| S-EPMC3235117 | biostudies-literature
| S-EPMC5442851 | biostudies-other
| S-EPMC5553786 | biostudies-literature
| S-EPMC8590870 | biostudies-literature
| S-EPMC5482483 | biostudies-literature
| S-EPMC3544697 | biostudies-literature
| S-EPMC3754657 | biostudies-literature
2012-01-19 | E-GEOD-35182 | biostudies-arrayexpress